지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 저널정보
- 아시아태평양암예방학회 Asian Pacific journal of cancer prevention : APJCP Asian Pacific journal of cancer prevention : APJCP 제16권 제17호
- 발행연도
- 2015.1
- 수록면
- 7,415 - 7,423 (9page)
이용수
초록· 키워드
오류제보하기
Chronic myeloid leukemia (CML) is a stem cell disorder characterized by unrestricted proliferation of the myeloid series that occurs due to the BCR-ABL fusion oncogene as a result of reciprocal translocation t(9;22) (q34;q11). This discovery has made this particular domain a target for future efforts to cure CML. Imatinib revolutionized the treatment options for CML and gave encouraging results both in case of safety as well as tolerability profile as compared to agents such as hydroxyurea or busulfan given before Imatinib. However, about 2-4% of patients show resistance and mutations have been found to be one of the reasons for its development. European Leukemianet gives recommendations for BCR-ABL mutational analysis along with other tyrosine kinase inhibitors (TKIs) that should be administered according to the mutations harbored in a patient. The following overview gives recommendations for monitoring patients on the basis of their mutational status.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
A case of e1a2 (minor, P190) BCR-ABL1-positive chronic myeloid leukemia in Korea
Blood Research
2021 .12
-
Genomic Profiling of Chronic Myelogenous Leukemia: Basic and Clinical Approach
대한암예방학회지
2017 .01
-
Tyrosine Kinase Inhibitors in Ph+ Chronic Myeloid Leukemia Therapy: a Review
Asian Pacific journal of cancer prevention : APJCP
2016 .01
-
An Overview and Update of Chronic Myeloid Leukemia for Primary Care Physicians
Korean Journal of Family Medicine
2015 .01
-
Concurrence of e1a2 and e19a2 BCR-ABL1 Fusion Transcripts in a Typical Case of Chronic Myeloid Leukemia
Annals of Laboratory Medicine
2017 .01
-
Chronic Myeloid Leukemia With Rare Variant b2a3 (e13a3) BCR-ABL1 Fusion
Annals of Laboratory Medicine
2016 .01
-
Promyelocytic Blast Phase of Chronic Myeloid Leukemia, BCR-ABL1 -Positive: Points to be Considered at Diagnosis
Annals of Laboratory Medicine
2021 .01
-
Concomitant AID Expression and BCL7A Loss Associates With Accelerated Phase Progression and Imatinib Resistance in Chronic Myeloid Leukemia
Annals of Laboratory Medicine
2017 .01
-
Detection of BCR/ABL Fusion Gene by Hematological and Cytogenetical Analysis in Chronic Myeloid Leukemia Patients in Quetta, Pakistan
Asian Pacific journal of cancer prevention : APJCP
2015 .01
-
Chronic myeloid leukemia: a type of MPN
Blood Research
2022 .06
-
Evaluation of a new flow cytometry based method for detection of BCR-ABL1 fusion protein in chronic myeloid leukemia
Blood Research
2017 .01
-
Minor BCR-ABL1-Positive Acute Myeloid Leukemia Associated With the NPM1 Mutation and FLT3 Internal Tandem Duplication
Annals of Laboratory Medicine
2016 .01
-
Chronic phase of chronic myeloid leukemia presenting with myeloid sarcoma in an adolescent
Blood Research
2020 .01
-
High rate of hepatitis B reactivation during tyrosine kinase inhibitor treatment among patients with chronic myeloid leukemia in Korea
Blood Research
2022 .12
-
Treatment and Survival in Patients with Chronic Myeloid Leukemia in a Chronic Phase in West Iran
Asian Pacific journal of cancer prevention : APJCP
2015 .01
-
A Novel e8a2BCR-ABL1 Fusion Transcript without Insertion Sequence in a Patient with Chronic Myeloid Leukemia
Annals of Laboratory Medicine
2018 .01
-
Parameters Involved in Autophosphorylation in Chronic Myeloid Leukemia: a Systems Biology Approach
Asian Pacific journal of cancer prevention : APJCP
2015 .01
-
A narrative review on adverse effects of dasatinib with a focus on pharmacotherapy of dasatinib-induced pulmonary toxicities
Blood Research
2021 .12
-
Dasatinib-induced reversible pulmonary arterial hypertension in a pediatric patient with BCR/ABL1+ lymphoblastic lymphoma from chronic myeloid leukemia
Blood Research
2022 .03
-
The incidence of atypical patterns of BCR-ABL1 rearrangement and molecular-cytogenetic response to tyrosine kinase inhibitor therapy in newly diagnosed cases with chronic myeloid leukemia (CML)
Blood Research
2018 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0